News from other websites on fdc
CCI orders probe against Cipla, 3 others for anti-competitive acts
May 10, 2013 at 13:32 | Source: Economic Times
NEW DELHI: Fair trade regulator the Competition Commission of India has ordered a probe against four pharmaceutical entities including drug-maker Cipla and one person for anti-competitive practices in Himachal Pradesh. Macleods Pharmaceuticals, FDC,...
Railway Minister Pawan Kumar Bansal in for more trouble as drug tests at family firm fail
May 07, 2013 at 20:47 | Source: Financial Express
More trouble is brewing for Union Railway Minister Pawan Kumar Bansal as the Standing Committee of Parliament on Health and Family Welfare has observed that 13 drugs including one manufactured at a Himachal Pradesh unit of the family members of the ...
Great Lakes to ink MoU with Brazil's top B-school FDC
Apr 03, 2013 at 16:46 | Source: The Hindu BusinessLine
Chennai, April 2: Great Lakes Institute of Management intends to tie up with the Brazilian B-school Fundação Dom Cabral (FDC). S. Sriram, Executive Director, GLIM, says the MoU, which it will sign soon with FDC, will promote a comparative study of...
Brazil’s top B-school FDC plans a connect with Indian IT firms
Apr 02, 2013 at 21:41 | Source: The Hindu BusinessLine
Chennai, April 2: There is a huge potential for Indian IT companies in Brazil and they need to leverage their strengths in the Latin American country. “The Brazilians look at India as a reference point,” says Carlos Arruda, Professor of ...
Federation Centres' Sewell Sees Online Rivals Spurring Retailers
Mar 03, 2013 at 08:00 | Source: Bloomberg
Australian retail outlets are improving operations and profitability in response to the challenge from online shopping rivals, said Steven Sewell, chief executive officer of shopping mall operator Federation Centres. (FDC). “What it's done,...
Dec quarter drug sales register slowest growth in 2012
Jan 13, 2013 at 06:26 | Source: The Hindu BusinessLine
Drug sales for December grew at 5.1 per cent, the slowest in 2012. Data compiled by market research firm AIOCD AWACS points to a sedate growth for the second consecutive month. This may be due to lower sales of branded generic drugs and slower new p...
Dec 24, 2012 at 17:02 | Source: India Infoline
FDC clocked volume of 19.65 lakh shares by 12:59 IST on BSE, a 129.89-times surge over two-week average daily volume of 15,000 shares. The stock jumped 9.97% at Rs 97.10.FDC during trading hours today, 24 December 2012 clarified on the news titled P...
Dec 24, 2012 at 14:22 | Source: Business Standard
FDC has soared 13% to Rs 100 on back of heavy volumes on report that the promoters of pharmaceutical company plan to sell majority of their stake in the company. The stock has opened at Rs 95.40 and hit a 52-week high of Rs 104.40 on the NSE. A combi...
FDC owners in talks to exit; plan to sell their 67% stake
Dec 24, 2012 at 10:56 | Source: Economic Times
MUMBAI: The Chandavarkar family, the promoters of pharma firm FDC, plan to sell their 67% stake in the company, people close to the company said. FDC, with a market cap of Rs 1,621 crore, has a strong portfolio of anti-infective drugs. Its brand Zif...
Mylan Labs selected to supply anti-retrovirals to S. Africa
Dec 01, 2012 at 21:57 | Source: The Hindu BusinessLine
Hyderabad, Dec. 1: Mylan Laboratories Ltd has been selected as one of the lead suppliers of anti-retroviral drugs to the South African Department of Health. The tender period is January 1, 2013 to December 31, 2014. Mylan Labs, based in Hyderabad wi...
Mylan Labs to supply anti-retrovirals to S. Africa
Dec 01, 2012 at 20:41 | Source: The Hindu BusinessLine
Hyderabad, Dec 1: Mylan Laboratories Ltd has been selected as one of the lead suppliers of anti-retroviral drugs to the South African Department of Health. The tender period is January 1, 2013 to December 31, 2014. Hyderabad-based Mylan Labs is the ...
Combination drugs come under Centre's scanner
Dec 01, 2012 at 05:26 | Source: DNA India
The Union Ministry of Health and Family Welfare is likely to curb the number of combination drugs that are sold in India, often with no discernible benefit to consumers. It may withdraw licences given to some 200 fixed dose combinations (FDCs) which ...
Combination drugs come under Centre�s scanner
Nov 29, 2012 at 13:06 | Source: DNA India
The Union Ministry of Health and Family Welfare is likely to curb the number of combination drugs that are sold in India, often with no discernible benefit to consumers. It may withdraw licences given to some 200 fixed dose combinations (FDCs) which ...
Pharma sales growth docile in Sept at 12%
Oct 16, 2012 at 04:02 | Source: The Hindu BusinessLine
Domestic pharma sales data for September suggests moderation in the growth. According to data released by market research firm AIOCD AWACS, the growth in secondary sales (sales at retailer level) for the industry was 12.1 per cent in September. This...
Cipla's anti-malaria drug gets WHO nodAims to make this treatment widely available throughout Asia
Oct 04, 2012 at 00:12 | Source: Business Standard
Drug firm Cipla today said an anti-malarial drug developed by Drugs for Neglected Diseases initiative (DNDi) has received pre-qualification from the World Health Organisation (WHO). The Mumbai-headquartered firm is manufacturing the fixed dose combin...
IIM-A ties up with top B-schools for 'BRICs on BRICs' programme
Jul 21, 2012 at 19:07 | Source: The Hindu BusinessLine
Ahmedabad, July 21: The Indian Institute of Management-Ahmedabad (IIM-A) on Saturday announced partnerships with top business schools in Brazil, Russia and China to offer a ‘BRICs on BRICs’ Programme, enabling participants to familiarise...
Indian Institute of Management-Ahmedabad designs formula for BRIC economies
Jun 18, 2012 at 18:32 | Source: Economic Times
AHMEDABAD: Trust the Indian Institutes of Management (IIMs) to stay abreast of the changing financial world. The premier business schools are rolling out courses and management development programmes for corporates in sync with the global uncertaint...
'Pharma firms sell common drugs at 10 times the cost'
Jun 16, 2012 at 01:32 | Source: The Hindu BusinessLine
New Delhi, June 15: Leading pharma companies, including GlaxoSmithkline, Pfizer and Ranbaxy, sell commonly used drugs at 10 times the cost of production, a study by the Corporate Affairs Ministry has found. A study by the Cost Audit branch of the MC...
Heard on the Street: FDC stock jumps 13% on promoter stake sale talk
May 29, 2012 at 04:02 | Source: Economic Times
Shares of Mumbai-based pharmaceutical company FDC have jumped 13% to Rs 84.90 in a fortnight amid buzz the company's promoters are planning sell their stakes to an overseas drugmaker. Promoters hold 66.9% stake in the company, which owns popular bra...
May 28, 2012 at 14:37 | Source: Business Standard
FDC Limited has rallied 9% to Rs 89.70 after the board approved buyback of equity shares at a maximum price of Rs 110 per share from the open market purchase. The board of directors has approved the buyback of fully paid-up equity shares of Re 1/- ea...










